| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |